Effect of zoledronic acid (ZA) on bone mineral density (BMD) in premenopausal women who develop ovarian failure (OF) due to adjuvant chemotherapy (AdC): First results from CALGB trial 7980 Meeting Abstract


Authors: Shapiro, C. L.; Halabi, S.; Gibson, G.; Weckstein, D. J.; Kirshner, J.; Sikov, W. M.; Winer, E. P.; Hudis, C. A.; Isaacs, C.; Weckstein, D.; Schilsky, R. L.; Paskett, E.
Abstract Title: Effect of zoledronic acid (ZA) on bone mineral density (BMD) in premenopausal women who develop ovarian failure (OF) due to adjuvant chemotherapy (AdC): First results from CALGB trial 7980
Meeting Title: 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 26
Issue: 15 Suppl.
Meeting Dates: 2008 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2008-05-20
Start Page: 9s
Language: English
ACCESSION: WOS:000208457400079
PROVIDER: wos
DOI: 10.1200/jco.2008.26.15_suppl.512
Notes: Meeting Abstract: 512 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Clifford Hudis
    904 Hudis